Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Charcot-Marie-Tooth disease, type 2H (CMT2H, also referred to as CMT4C2) is an axonal CMT peripheral sensorimotor polyneuropathy associated with pyramidal involvement.
Features include always present findings: Distal muscle weakness. 11 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 2 | Steppage gait, Upper limb hyperreflexia |
Muscles |
Biomarker and diagnostic research for Charcot-Marie-Tooth disease axonal type 2H has been reported in the published literature.
Phenotype severity distribution: 1 always present feature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
1 clinical trial registered, 1 recruiting. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
75 publications have been identified in PubMed for Charcot-Marie-Tooth disease axonal type 2H. Research spans Basic Science / Preclinical (33%), Case Report / Case Series (23%), and Epidemiology / Natural History (15%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 25 |
Data assembled from 6 of 12 sources · Last updated Sep 20, 2026, 2:05 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Charcot-Marie-Tooth disease axonal type 2H
2
Distal muscle weakness, Foot dorsiflexor weakness |
Arms and legs | 2 | Upper limb hyperreflexia, Foot dorsiflexor weakness |
Patient case studies | 17 | 23% |
Disease patterns and progression | 11 | 15% |
Research summaries | 10 | 13% |
Other research | 5 | 7% |
New treatment approaches | 3 | 4% |
Testing and diagnosis research | 2 | 3% |
Clinical study results | 2 | 3% |
Turnes BL (2026). [PMID: 41867828](https://pubmed.ncbi.nlm.nih.gov/41867828/). *bioRxiv*. [Gene Therapy / Novel Therapeutics]
Martín-Jimenez P (2026). [PMID: 41571587](https://pubmed.ncbi.nlm.nih.gov/41571587/). *J Inherit Metab Dis*. [Basic Science / Preclinical]
Breijo M (2026). [PMID: 41914324](https://pubmed.ncbi.nlm.nih.gov/41914324/). *Lab Anim*. [Basic Science / Preclinical]
Agianda HAP (2026). [PMID: 41365832](https://pubmed.ncbi.nlm.nih.gov/41365832/). *Mov Disord*. [Epidemiology / Natural History]
Wang L (2026). [PMID: 40888368](https://pubmed.ncbi.nlm.nih.gov/40888368/). *Clin Genet*. [Case Report / Case Series]
Saini L (2026). [PMID: 42175818](https://pubmed.ncbi.nlm.nih.gov/42175818/). *J Child Neurol*. [Other]
Salami Z (2026). [PMID: 41538925](https://pubmed.ncbi.nlm.nih.gov/41538925/). *Neuromuscul Disord*. [Basic Science / Preclinical]
Riboldi GM (2026). [PMID: 30137827](https://pubmed.ncbi.nlm.nih.gov/30137827/). *Unknown Journal*. [Basic Science / Preclinical]
Zhu L (2026). [PMID: 41721346](https://pubmed.ncbi.nlm.nih.gov/41721346/). *Orphanet J Rare Dis*. [Epidemiology / Natural History]
Lamichhane A (2026). [PMID: 32809579](https://pubmed.ncbi.nlm.nih.gov/32809579/). *Unknown Journal*. [Basic Science / Preclinical]